Literature DB >> 22491341

Editorial commentary: Hepatitis C virus and the infectious disease physician: a perfect match.

Barbara H McGovern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22491341     DOI： 10.1093/cid/cis378

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals.

Authors:  Mark S Roberts; Fasiha Kanwal; Jagpreet Chhatwal; Xiaojie Wang; Turgay Ayer; Mina Kabiri; Raymond T Chung; Chin Hur; Julie M Donohue
Journal:  Hepatology       Date:  2016-06-01       Impact factor: 17.425

2.  Direct-acting antiviral treatment for HIV/HCV patients in safety net settings: patient and provider preferences.

Authors:  Martha Shumway; Anne F Luetkemeyer; Marion G Peters; Mallory O Johnson; Tessa M Napoles; Elise D Riley
Journal:  AIDS Care       Date:  2019-03-04

Review 3.  Closing the hepatitis C treatment gap: United States strategies to improve retention in care.

Authors:  Austin T Jones; Christopher Briones; Torrence Tran; Lisa Moreno-Walton; Patricia J Kissinger
Journal:  J Viral Hepat       Date:  2022-05-26       Impact factor: 3.517

4.  Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians.

Authors:  Douglas S Krakower; Susan E Beekmann; Philip M Polgreen; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

5.  The changing burden of hepatitis C virus infection in the United States: model-based predictions.

Authors:  Mina Kabiri; Alison B Jazwinski; Mark S Roberts; Andrew J Schaefer; Jagpreet Chhatwal
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

Review 6.  Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.

Authors:  Jason Grebely; Megan Oser; Lynn E Taylor; Gregory J Dore
Journal:  J Infect Dis       Date:  2013-03       Impact factor: 5.226

7.  Hepatitis C Treatment and Barriers to Eradication.

Authors:  Monica A Konerman; Anna S F Lok
Journal:  Clin Transl Gastroenterol       Date:  2016-09-22       Impact factor: 4.488
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.